1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Generation of the iPSC line FINi002-A from a male Parkinson's disease patient carrying compound heterozygous mutations in the PRKN gene
(
- Contribution to journal › Article
- 2017
-
Mark
Gene therapy for Parkinson's disease : Disease modification by GDNF family of ligands
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Controlled striatal DOPA production from a gene delivery system in a rodent model of Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A doctor's dilemma
(
- Contribution to journal › Article
- 2013
-
Mark
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntingtons disease
(
- Contribution to journal › Article
- 2012
-
Mark
Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system
(
- Contribution to journal › Article
-
Mark
Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's Disease.
(
- Contribution to journal › Article
-
Mark
alpha-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
(
- Contribution to journal › Article
- 2010
-
Mark
Differential Transduction Following Basal Ganglia Administration of Distinct Pseudotyped AAV Capsid Serotypes in Nonhuman Primates
(
- Contribution to journal › Article
- 2009
-
Mark
Dose Optimization for Long-term rAAV-mediated RNA Interference in the Nigrostriatal Projection Neurons.
(
- Contribution to journal › Article